Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 2496* | 2021 |
The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths A Kasturiratne, AR Wickremasinghe, N de Silva, NK Gunawardena, ... PLoS medicine 5 (11), e218, 2008 | 2194 | 2008 |
Manson's Tropical Infectious Diseases J Farrar, PJ Hotez, T Junghanss, G Kang, D Lalloo, NJ White, PJ Garcia Elsevier health sciences, 2023 | 998* | 2023 |
The impact of COVID-19 and strategies for mitigation and suppression in low-and middle-income countries PGT Walker, C Whittaker, OJ Watson, M Baguelin, P Winskill, A Hamlet, ... Science 369 (6502), 413-422, 2020 | 959 | 2020 |
Snake envenoming: a disease of poverty RA Harrison, A Hargreaves, SC Wagstaff, B Faragher, DG Lalloo PLoS neglected tropical diseases 3 (12), e569, 2009 | 694 | 2009 |
Combination antifungal therapy for cryptococcal meningitis JN Day, TTH Chau, M Wolbers, PP Mai, NT Dung, NH Mai, NH Phu, ... New England Journal of Medicine 368 (14), 1291-1302, 2013 | 628 | 2013 |
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults N French, K Gray, C Watera, J Nakiyingi, E Lugada, M Moore, D Lalloo, ... Aids 16 (7), 1031-1038, 2002 | 518 | 2002 |
Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants P Klenerman, S Rowland-Jones, S McAdam, J Edwards, S Daenke, ... Nature 369 (6479), 403-407, 1994 | 506 | 1994 |
Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part 1: determinants operating at individual and household level I Bates, C Fenton, J Gruber, D Lalloo, AM Lara, SB Squire, S Theobald, ... The Lancet infectious diseases 4 (5), 267-277, 2004 | 435 | 2004 |
Antigenic oscillations and shifting immunodominance in HIV-1 infections MA Nowak, RM May, RE Phillips, S Rowland-Jones, DG Lalloo, ... Nature 375 (6532), 606-611, 1995 | 393 | 1995 |
Antifungal combinations for treatment of cryptococcal meningitis in Africa SF Molloy, C Kanyama, RS Heyderman, A Loyse, C Kouanfack, ... New England Journal of Medicine 378 (11), 1004-1017, 2018 | 391 | 2018 |
Adjunctive dexamethasone in HIV-associated cryptococcal meningitis J Beardsley, M Wolbers, FM Kibengo, ABM Ggayi, A Kamali, NTK Cuc, ... New England Journal of Medicine 374 (6), 542-554, 2016 | 341 | 2016 |
UK malaria treatment guidelines DG Lalloo, D Shingadia, G Pasvol, PL Chiodini, CJ Whitty, NJ Beeching, ... Journal of infection 54 (2), 111-121, 2007 | 326 | 2007 |
Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa M Scarborough, SB Gordon, CJM Whitty, N French, Y Njalale, A Chitani, ... New England Journal of Medicine 357 (24), 2441-2450, 2007 | 308 | 2007 |
Neurotoxicity in snakebite—the limits of our knowledge UK Ranawaka, DG Lalloo, HJ de Silva PLoS neglected tropical diseases 7 (10), e2302, 2013 | 283 | 2013 |
Artesunate versus quinine for treating severe malaria D Sinclair, S Donegan, R Isba, DG Lalloo Cochrane Database of Systematic Reviews, 2012 | 279 | 2012 |
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 259 | 2022 |
Prevention of Jarisch–Herxheimer reactions by treatment with antibodies against tumor necrosis factor α D Fekade, K Knox, K Hussein, A Melka, DG Lalloo, RE Coxon, DA Warrell New England Journal of Medicine 335 (5), 311-315, 1996 | 243 | 1996 |
Snake antivenoms: antivenoms DG Lalloo*, RDG Theakston Journal of Toxicology: Clinical Toxicology 41 (3), 277-290, 2003 | 231 | 2003 |
Effect of optional home initiation of HIV care following HIV self-testing on antiretroviral therapy initiation among adults in Malawi: a randomized clinical trial P MacPherson, DG Lalloo, EL Webb, H Maheswaran, AT Choko, ... Jama 312 (4), 372-379, 2014 | 228 | 2014 |